Ceapro Inc (CRPOF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRPOF | AZN | AMGN | GILD | BMY |
| Company | Ceapro Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | OTC US | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.1700 | 185.45 | 332.52 | 130.00 | 60.02 |
| High | 0.1700 | 187.18 | 337.00 | 132.14 | 60.09 |
| Low | 0.1700 | 184.01 | 324.63 | 129.01 | 58.03 |
| Latest | 0.1700 | 185.28 | 328.61 | 132.26 | 58.63 |
| Change | -0.0255 | -2.09 | -17.64 | +1.42 | -1.96 |
| % Change | -13.04% | -1.12% | -5.09% | +1.09% | -3.23% |
| Volume | 6,000 | 1,302,606 | 2,347,398 | 2,327,282 | 10,314,567 |
| 20-Day Average Volume | 17,930 | 2,010,097 | 2,479,153 | 5,176,566 | 9,414,327 |
| Previous Close | 0.1955 | 187.37 | 346.25 | 130.84 | 60.59 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.1832 | 196.77 | 345.90 | 135.59 | 58.76 |
| 20-Day Raw Stochastic | 14.09% | 14.00% | 7.55% | 28.18% | 33.71% |
| 20-Day Relative Strength | 47.81 | 40.02 | 37.22 | 41.86 | 48.68 |
| Weighted Alpha | -56.17 | +24.15 | +12.36 | +22.69 | +20.28 |
| Today's Opinion | 56% Sell | 40% Buy | 8% Sell | 8% Buy | 40% Buy |
| Previous Opinion | 40% Sell | 40% Buy | 8% Buy | Hold | 72% Buy |
| Last Month's Opinion | 88% Sell | 80% Buy | 40% Buy | 40% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -22.73% since 05/15/24 | -2.34% since 04/24/26 | -5.02% since 04/24/26 | +1.20% since 04/24/26 | -0.49% since 04/24/26 |
| Low | 0.1700 on 05/31/24 | 181.73 on 04/29/26 | 324.63 on 05/01/26 | 127.64 on 04/27/26 | 57.28 on 04/29/26 |
| High | 0.2060 on 05/16/24 | 190.59 on 04/27/26 | 349.54 on 04/30/26 | 132.21 on 04/30/26 | 60.78 on 04/30/26 |
| 1-Month | |||||
| %Chg | -7.86% since 04/22/24 | -7.68% since 04/01/26 | -7.37% since 04/01/26 | -5.94% since 04/01/26 | -5.36% since 04/01/26 |
| Low | 0.1700 on 05/31/24 | 181.73 on 04/29/26 | 324.63 on 05/01/26 | 127.64 on 04/27/26 | 57.22 on 04/15/26 |
| High | 0.2200 on 05/15/24 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 60.78 on 04/30/26 |
| 3-Month | |||||
| %Chg | +6.25% since 02/28/24 | -0.12% since 01/30/26 | -4.28% since 01/30/26 | -7.04% since 01/30/26 | +6.12% since 01/30/26 |
| Low | 0.1618 on 03/08/24 | 181.73 on 04/29/26 | 324.63 on 05/01/26 | 127.64 on 04/27/26 | 54.96 on 02/02/26 |
| High | 0.2200 on 05/15/24 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -7.66% since 11/29/23 | +12.45% since 10/31/25 | +9.66% since 10/31/25 | +10.16% since 10/31/25 | +26.81% since 10/31/25 |
| Low | 0.1146 on 01/29/24 | 160.96 on 11/04/25 | 292.12 on 11/03/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 0.2200 on 05/15/24 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 13,310 | 290,593,632 | 186,865,936 | 162,401,488 | 123,708,720 |
| Shares Outstanding, K | 78,293 | 1,550,908 | 539,685 | 1,241,222 | 2,041,735 |
| Annual Sales | 7,140,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -3,490,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 1,210,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -1,570,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 1.47 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.02 on 05/29/24 | 2.12 on 02/10/26 | 5.15 on 04/30/26 | 1.86 on 02/10/26 | 1.58 on 04/30/26 |
| Earnings Date | 09/03/24 | 08/04/26 | 04/30/26 | 05/07/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.00 | 15.47 | 15.81 | 9.36 |